Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma

被引:16
作者
Li Mingzhu [1 ]
Zhao Lijun [1 ]
Shen Danhua [1 ]
Li Xiaoping [1 ]
Wang Jianliu [1 ]
Wei Lihui [1 ]
机构
[1] Peking Univ, Dept Obstet & Gynecol, Peoples Hosp, Beijing 100044, Peoples R China
基金
中国国家自然科学基金;
关键词
endometrial carcinoma; immunohistochemistry; clinical factors; biomarkers; P53; CANCER; EXPRESSION; RECEPTOR; KI-67; PTEN; ANGIOGENESIS; PROTEIN; BCL-2; KI67;
D O I
10.3760/cma.j.issn.0366-6999.20132774
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Endometrial carcinoma is one of the most common gynecological cancers and the incidence has been increasing. This study was to identify the relationship of estrogen receptor (ER), progestrone receptor (PR), P53 protein, Ki-67 and phosphatase and tensin homolog deleted on chromosome ten (PTEN) with endometrial carcinoma, the assessment of these bionnarkers and their association with clinicopathological parameters was performed. Methods A total of 198 cases of primary endometrial carcinoma were investigated for ER, PR, Ki-67, P53, and PTEN antigens by immunohistochemical methods. The association of these markers with age, menopause status, histological type, FIGO stage, grading, depth of invasion, lymph node involvement and serum tumor marker was examined. Results The percentages of Ki-67- and P53-negative endometrial tumors were significantly higher in ER-positive compared with ER-negative tumors (both P=0.000). The same trend was evident with PR status. The percentage of PTEN-positive tumors was significantly higher in PR-positive compared with PR-negative tumors (P=0.021), but was no difference in tumors with different ER status. There was no clear association between PTEN positivity and clinicopathological parameters except more relevance with endometrioid histotype (P=0.013). There was a statistically significant difference in the distribution of the different combined biological factors examined in disease-free survival. Conclusions ER and PR status were significant predictors with staging, grading and recurrence. P53 and Ki-67 expression were inversely correlated with both ER and PR expression and have more aggressive clinicopathological features. PTEN expression was inversely correlated with PR expression but not with ER expression. The combined type of ER+PR+P53-PTEN+ was in the majority in endometrial cancer and seemed to be related to better clinical outcome. The combination of ER PR P53+PTEN- represented the worst disease-free survival and was strongly associated with
引用
收藏
页码:1459 / 1463
页数:5
相关论文
共 24 条
[1]   Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in International Federation of Gynecology and Obstetrics stage 1 and 2 endometrial carcinoma [J].
Baak, JPA ;
Snijders, W ;
van Diermen, B ;
van Diest, PJ ;
Diepenhorst, FW ;
Benraadt, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4214-4221
[2]   INFLUENCE OF CYTOPLASMIC STEROID-RECEPTOR CONTENT ON PROGNOSIS OF EARLY STAGE ENDOMETRIAL CARCINOMA [J].
CREASMAN, WT ;
SOPER, JT ;
MCCARTY, KS ;
MCCARTY, KS ;
HINSHAW, W ;
CLARKEPEARSON, DL .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 151 (07) :922-932
[3]   Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer [J].
Fanning, J ;
Brown, S ;
Phibbs, G ;
Kramer, T ;
Zaher, A .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (03) :286-289
[4]   Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer [J].
Ferrandina, G ;
Ranelletti, FO ;
Gallotta, V ;
Martinelli, E ;
Zannoni, GF ;
Gessi, M ;
Scambia, G .
GYNECOLOGIC ONCOLOGY, 2005, 98 (03) :383-389
[5]  
Halperin R, 2001, EUR J GYNAECOL ONCOL, V22, P122
[6]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
[7]   p53 alteration independently predicts poor outcomes in patients with endometrial cancer: A clinicopathologic study of 131 cases and literature review [J].
Lee, Eun-Ju ;
Kim, Tae-Joong ;
Kim, Dae Shick ;
Choi, Chel Hun ;
Lee, Jeong-Won ;
Lee, Je-Ho ;
Bae, Duk-Soo ;
Kim, Byoung-Gie .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :533-538
[8]   Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers [J].
Lee, Yoo-Kyung ;
Park, Noh-Hyun .
GYNECOLOGIC ONCOLOGY, 2009, 112 (03) :475-480
[9]   Surgical stage I endometrial cancer: Predictors of distant failure and death [J].
Mariani, A ;
Webb, MJ ;
Keeney, GL ;
Lesnick, TG ;
Podratz, KC .
GYNECOLOGIC ONCOLOGY, 2002, 87 (03) :274-280
[10]   Selected Immunohistochemical Prognostic Factors in Endometrial Cancer [J].
Markova, Ivana ;
Duskova, Milada ;
Lubusky, Marek ;
Kudela, Milan ;
Zapletalova, Jana ;
Prochazka, Martin ;
Pilka, Radovan .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (04) :576-582